Dyslipidemia Completed Phase Trials for Ezetimibe (DB00973)

Also known as: Dyslipaemia / Dyslipidaemia / Dyslipidemias / Dyslipidaemias

IndicationStatusPhase
DBCOND0020718 (Dyslipidemia)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02304926Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With DyslipidemiaTreatment
NCT00726856Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)